Complete Guide to the Overseas IVF Cycle: Stage-by-Stage Timeline and Key Considerations

An overseas IVF cycle typically includes seven stages: initial consultation and assessment, ovarian stimulation, egg and sperm retrieval, embryo culture, PGT testing, frozen embryo transfer, luteal phase support and pregnancy test. A full cycle takes about 2-3 months, with ovarian stimulation lasting 10-14 days and embryo culture plus PGT testing taking 2-4 weeks. This article breaks down each stage, timeline, and key considerations.

Complete Guide to the Overseas IVF Cycle: Stage-by-Stage Timeline and Key Considerations
Surrogacy process 2026-07-28

AI Summary

AI Summary
An overseas IVF cycle refers to the complete medical process from initial consultation to pregnancy test, typically comprising seven core stages: initial consultation and fertility assessment (1-2 days), ovarian stimulation (10-14 days), egg and sperm retrieval (1 day), embryo culture (3-6 days), PGT genetic testing (2-4 weeks), frozen embryo transfer (1 day), and luteal phase support and pregnancy test (12-14 days). A full cycle takes about 2-3 months, depending on whether PGT testing is performed, the embryo culture protocol, and individual health conditions. It is suitable for individuals with normal ovarian function, blocked fallopian tubes, male factor infertility, or carriers of genetic diseases; it is not suitable for patients with severe uterine abnormalities or uncontrolled systemic diseases.
Opening: Real Consultation Scenario
Reproductive Medicine Center · Doctor's Notes
"Doctor, I had one IVF cycle in my home country last year and it was unsuccessful. Now I'm considering going abroad for IVF, but I have no idea about the entire overseas IVF cycle, how long it takes, and whether the process differs from what I experienced at home." This was a question from a 38-year-old patient I saw in the clinic last week. Her situation is quite representative—she had one failed transfer, an AMH level of 1.8 ng/mL, and bilaterally patent but not freely open fallopian tubes. What she needs is not an advertisement, but a clear roadmap of the cycle.
==================== Main Content Begins ====================

Definition and Core Stages of an Overseas IVF Cycle

An overseas IVF cycle refers to the complete medical process starting from the patient's first medical evaluation at a fertility center to confirming pregnancy after embryo transfer. A standard cycle consists of seven consecutive stages, which are closely linked in time, but the specific schedule may be adjusted based on individual circumstances, embryo development status, and whether genetic testing is performed.

Stage Core Content Time Required Key Decision Points
① Initial Consultation & Assessment Fertility tests, AMH/FSH/LH/antral follicle count, semen analysis, chromosome karyotype, infectious disease screening, genetic counseling, uterine cavity assessment 1-2 days (some tests require advance booking) Determine IVF indications, choose stimulation protocol, decide on PGT necessity
② Ovarian Stimulation Use of gonadotropins for ovarian stimulation, regular monitoring of follicle development and hormone levels 10-14 days Adjust medication dosage, determine trigger timing
③ Egg & Sperm Retrieval Transvaginal ultrasound-guided egg retrieval, simultaneous sperm collection from male partner 1 day Assess number of eggs retrieved, sperm quality
④ Embryo Culture Intracytoplasmic sperm injection (ICSI) or conventional fertilization, embryo culture in vitro to blastocyst stage 3-6 days Select embryo for transfer or proceed with PGT biopsy
⑤ PGT Genetic Testing (Optional) Blastocyst trophectoderm biopsy for chromosomal number/structure abnormalities or single gene disorder testing 2-4 weeks Screen for normal embryos suitable for transfer
⑥ Frozen Embryo Transfer Endometrial preparation (natural or artificial cycle), thawing and transferring embryos into the uterine cavity 1 day (endometrial preparation approx. 10-14 days) Determine implantation window, choose single or double embryo transfer
⑦ Luteal Phase Support & Pregnancy Test Use of progesterone medications to support the endometrium after transfer, blood test for β-hCG 12-14 days later 12-14 days Confirm biochemical pregnancy, schedule follow-up ultrasound
AMHFSHLHAntral FolliclesSemen AnalysisChromosome TestingGenetic CounselingUterine Cavity ExamPGTLuteal Phase Support
===== Actual Process + Timeline =====

Detailed Process and Timeline for Each Stage

The following breaks down each stage in the actual order of occurrence, including specific procedures, timeframes, and patient responsibilities.

Stage 1: Initial Consultation and Fertility Assessment

Tests required for the female partner include: AMH, FSH, LH, estradiol, thyroid function, infectious disease screening (Hepatitis B, Hepatitis C, HIV, Syphilis), chromosome karyotype, and uterine cavity ultrasound or hysteroscopy. The male partner needs to complete a semen analysis (including morphology and DNA fragmentation), infectious disease screening, and chromosome karyotype. If there is a family history of genetic diseases, genetic counseling is also necessary.

Timeline: Most blood tests can be completed within 1 day, but chromosome karyotype analysis usually takes 7-14 days for results. Hysteroscopy requires an appointment, often scheduled 3-7 days after the end of menstruation. It is recommended to start tests 1-2 months in advance to allow sufficient time to address any abnormal results.

Required Documents: Passport (valid for at least 6 months), visa, previous medical records and surgical reports, recent test reports (domestic reports may need translation and notarization). Some overseas centers may require a referral letter from a domestic tertiary hospital or a medical translation document.

Stage 2: Ovarian Stimulation

Based on the woman's age, AMH, antral follicle count, and previous response, the fertility specialist will choose an appropriate ovarian stimulation protocol. Common protocols include the antagonist protocol, long protocol, short protocol, and PPOS protocol. During stimulation, patients need to return to the clinic every 2-3 days for monitoring of follicle development (ultrasound + hormone levels), and medication dosage is adjusted based on follicle size and hormone levels.

Timeline: Ovarian stimulation typically lasts 10-14 days. When at least 2-3 follicles reach 18-20 mm in diameter, hCG or a GnRH agonist is administered to trigger ovulation, and egg retrieval is scheduled 36 hours later.

What to Watch For: During stimulation, you may experience bloating and ovarian enlargement; avoid strenuous exercise. Maintain a high-protein, easily digestible diet and drink plenty of water. If you experience severe bloating, decreased urination, or difficulty breathing, contact your doctor immediately to rule out Ovarian Hyperstimulation Syndrome (OHSS).

Stage 3: Egg and Sperm Retrieval

Egg retrieval is performed under intravenous sedation. A needle is guided transvaginally via ultrasound to puncture the follicles and aspirate the follicular fluid. The procedure takes about 15-30 minutes. After the procedure, you will rest in the recovery room for 1-2 hours before being discharged. The male partner provides a semen sample on the day of retrieval; if a frozen sample was previously prepared, his presence is not required.

Timeline: The egg retrieval procedure itself takes only 1 day, but you should rest for 24 hours afterward, avoiding driving and strenuous activity.

Risks: Egg retrieval may cause post-operative bleeding, infection, or ovarian torsion, but the incidence is low (approximately 0.1-0.5%). Seek immediate medical attention if you experience persistent abdominal pain, fever, or heavy vaginal bleeding after the procedure.

Stage 4: Embryo Culture

Fertilization (IVF or ICSI) is performed 4-6 hours after egg retrieval, and the fertilized eggs are cultured in an incubator. They are typically cultured to the blastocyst stage (day 5 or 6) for transfer or biopsy. If a fresh cycle transfer is chosen, it occurs on day 5 or 6; if all embryos are to be frozen, they are cultured further and then cryopreserved.

Timeline: From egg retrieval to blastocyst formation takes approximately 5-6 days. If PGT testing is performed, an additional 2-4 weeks is required.

Stage 5: PGT Genetic Testing (Optional)

PGT (Preimplantation Genetic Testing) comes in three types: PGT-A (aneuploidy screening), PGT-M (monogenic disorder testing), and PGT-SR (structural rearrangement testing). Biopsy is usually performed on day 5 or 6 blastocysts, removing 3-5 trophectoderm cells for analysis.

Timeline: From biopsy to receiving the test report takes about 2-4 weeks, depending on the type of test and the lab's schedule. PGT-A is relatively faster, while PGT-M requires building a family linkage analysis, which takes longer.

Suitable Candidates: Advanced maternal age (≥38 years), recurrent pregnancy loss, carriers of chromosomal abnormalities, severe male factor infertility, history of abnormal PGT results, or family history of genetic diseases.

Unsuitable Candidates: Individuals with very low ovarian reserve (AMH < 0.5 ng/mL) resulting in very few blastocysts available; after full counseling, the risks and benefits of biopsy must be weighed.

Stage 6: Frozen Embryo Transfer

The endometrium needs to be prepared before transfer. A natural cycle is suitable for patients with regular periods and normal ovulation; an artificial cycle is used for those with ovulation disorders or who need flexible scheduling. When the endometrial thickness reaches 7-12 mm with a trilaminar pattern, the transfer procedure is scheduled. The transfer itself takes about 5-10 minutes and does not require anesthesia.

Timeline: Endometrial preparation takes about 10-14 days, and the transfer procedure takes 1 day. After transfer, it is recommended to rest for 30 minutes before resuming normal activities.

Stage 7: Luteal Phase Support and Pregnancy Test

Progesterone medication (oral, vaginal gel, or injection) is started on the day of transfer to support luteal function. A blood test for β-hCG is performed 12-14 days after transfer to confirm pregnancy. If pregnant, luteal support continues until 8-10 weeks of gestation; if not, medication is stopped, menstruation will occur, and the next cycle can be prepared.

What to Watch For: During luteal phase support, you may experience bloating, breast tenderness, fatigue, or other symptoms similar to early pregnancy; these are normal. Do not stop progesterone or use other hormonal medications on your own.

===== Differences by Age Group =====

Impact of Age on the Overseas IVF Cycle

Age is one of the most critical factors influencing the choice of protocol and success rates in an overseas IVF cycle. Significant differences exist across age groups in ovarian response, embryo chromosomal abnormality rates, and transfer strategies.

Age Group Typical Characteristics Cycle Adjustment Direction Common Concerns
< 35 years Good ovarian reserve, AMH usually > 2.0 ng/mL, antral follicle count > 10 Standard stimulation protocol; fresh or frozen transfer both viable; PGT not mandatory Avoid overstimulation, control number of eggs retrieved, prevent OHSS
35-40 years Ovarian reserve begins to decline, AMH 1.0-2.0 ng/mL, fewer follicles Prefer antagonist or PPOS protocol; PGT-A screening recommended Increased embryo chromosomal abnormality rate (approx. 30-50%); ensure sufficient blastocyst numbers
40-42 years Significantly reduced ovarian reserve, AMH 0.5-1.0 ng/mL, antral follicle count < 8 Mild stimulation or natural cycle protocol; PGT-A mandatory; may require multiple cycles to accumulate blastocysts Few eggs per cycle, chromosomal abnormality rate approx. 60-80%; manage psychological expectations
> 42 years Very low ovarian reserve, AMH < 0.5 ng/mL, very few usable follicles Individualized mild stimulation, consider egg donation; PGT-A strongly recommended High cycle cancellation rate, live birth rate per cycle < 5%; comprehensive health assessment needed

AMH level is an important indicator of ovarian reserve but is not the sole determining factor. Patients with low AMH can still attempt an overseas IVF cycle, but expectations need to be adjusted—multiple cycles may be needed to accumulate embryos, or egg donation may be considered.

===== Differences by Country =====

Differences in Overseas IVF Cycles by Country

Different countries have variations in medical procedures, legal policies, and cycle scheduling, which directly affect cycle length and patient experience.

United States

Cycles at US fertility centers are typically managed in segments: initial assessment 1-2 days, ovarian stimulation 10-12 days, embryo culture and PGT testing about 3-4 weeks, and frozen embryo transfer scheduling is flexible. The US has extensive experience in PGT testing and genetic counseling, with high laboratory standards. The total cycle duration is about 2-3 months, but some centers have waiting lists, potentially extending the overall wait time to 3-4 months.

Thailand

Overseas IVF cycles in Thailand are known for efficiency and relatively transparent pricing. Initial assessment takes 1 day, ovarian stimulation 10-14 days, PGT testing about 2-3 weeks, and frozen embryo transfer can be done in the next menstrual cycle. The overall cycle is about 2 months. Some centers offer "one-stop" services, but it is important to choose laboratories with international accreditations (e.g., CAP, JCI).

Japan

Japanese fertility centers are characterized by meticulous, low-dose stimulation protocols, emphasizing individualization. Ovarian stimulation may extend to 12-16 days, and PGT testing takes 2-3 weeks. Japanese law strictly regulates embryo genetic testing, allowing only PGT-A and prohibiting sex selection. The total cycle duration is about 2-3 months.

Malaysia

Overseas IVF cycles in Malaysia offer good value for money. Initial assessment takes 1-2 days, ovarian stimulation 10-14 days, and PGT testing about 2-3 weeks. Some centers use "mild stimulation + natural cycle" protocols, suitable for patients with low ovarian reserve or advanced age. The total cycle duration is about 2 months. It is important to choose centers with MOH (Ministry of Health) certification and international-standard laboratories.

===== Most Commonly Overlooked Details =====

Most Commonly Overlooked Details in an Overseas IVF Cycle

Based on clinical observations, the following six details are most often overlooked by patients during an overseas IVF cycle, yet they can significantly impact the smooth progression of the entire process.

  • Passport validity less than 6 months: Most countries require a passport valid for at least 6 months upon entry; otherwise, you may be denied entry or unable to apply for a medical visa. Check your passport's validity before departure.
  • Validity of test reports: Results for AMH, hormone panel, and semen analysis are typically valid for 3-6 months. Chromosome karyotype and infectious disease screening reports are valid for 6-12 months. Expired reports will need to be repeated, delaying the start of the cycle.
  • Incomplete previous surgical records: If you have had hysteroscopy, laparoscopy, ovarian cystectomy, or tubal surgery, you need to provide complete surgical records and pathology reports. Missing key information may lead the doctor to order new tests.
  • Failure to confirm laboratory accreditation in advance: Some overseas centers' laboratories lack international accreditation (e.g., CAP, JCI, ISO15189), which may affect embryo culture quality or the reliability of PGT results. Request laboratory accreditation documents before starting the cycle.
  • Ignoring jet lag and schedule adjustment: Frequent monitoring during ovarian stimulation, combined with jet lag, can cause fatigue and hormonal fluctuations. Arrive at the destination early to adjust to the time difference and maintain a regular routine.
  • Insufficient supply of luteal phase support medication: Progesterone medication is needed for at least 8-10 weeks after transfer. If bringing medication back from overseas, ensure you have an adequate supply and understand cold chain transport requirements.
===== The Doctor's Perspective =====

Doctor's Perspective: How to Plan an Overseas IVF Cycle

As a reproductive specialist, when evaluating whether a patient is suitable to start an overseas IVF cycle, I focus on the following three aspects:

First, is the body "ready"? Not all patients are suitable to start a cycle immediately. If there are uncontrolled thyroid disorders, hyperprolactinemia, endometrial polyps, or intrauterine adhesions, these need to be addressed first. For patients with AMH < 1.0 ng/mL, I recommend 1-2 months of ovarian pre-treatment (e.g., DHEA, Coenzyme Q10) before starting the cycle.
Second, is the cycle protocol "individualized"? Even within an overseas IVF cycle, the protocol for a 35-year-old is completely different from that for a 42-year-old. For older patients, I prefer a strategy of "mild stimulation + embryo accumulation + PGT" rather than maximizing egg yield in a single cycle. For patients with recurrent implantation failure, I recommend endometrial microbiome testing or immune screening before the cycle.
Third, are psychological expectations "realistic"? An overseas IVF cycle is not a guarantee of "one-time success." Before starting the cycle, I have a detailed discussion with the patient about the ideal number of eggs, potential embryo attrition rates, and backup plans if the cycle fails. Psychological stress is an important factor affecting endocrine function and ovarian response; managing expectations is itself part of the treatment.
===== Practitioner Observations =====

Practitioner Observations: Common Issues and Solutions

In coordinating overseas IVF cycles, I have observed several recurring issues. Being aware of them in advance can help patients avoid unnecessary detours.

Issue 1: Asynchronous follicle development during stimulation.
Some patients experience uneven follicle sizes after stimulation, resulting in fewer eggs retrieved than expected. This is due to declining ovarian reserve or uneven response to stimulation. The solution is to assess AMH and antral follicle count before the cycle, choose a more suitable protocol (e.g., PPOS or mild stimulation), and adjust medication dosage promptly during stimulation.

Issue 2: No transferable embryos after PGT testing.
This is the most dreaded outcome for older patients or those with chromosomal abnormalities. Data shows that for patients over 40, approximately 6-8 out of every 10 blastocysts are chromosomally abnormal. Ways to reduce risk include: undergoing multiple egg retrieval cycles to accumulate blastocysts, choosing an experienced PGT laboratory, and having genetic counseling before the cycle.

Issue 3: Luteal phase insufficiency after transfer.
Some patients experience a drop in progesterone levels after transfer, affecting embryo implantation. This is related to individual metabolic differences or poor medication absorption. It is recommended to monitor progesterone levels 5-7 days after transfer and supplement with injectable progesterone if necessary.

===== Ending: Risk Reminder =====
Risk Reminder
Overseas IVF cycles involve multiple aspects such as cross-border medical care, medication transport, and language communication, carrying both medical and non-medical risks. Medical risks include: Ovarian Hyperstimulation Syndrome (OHSS), complications from egg retrieval, multiple pregnancies, and embryo transfer failure. Non-medical risks include: visa rejection, difficulty in handling medical disputes, communication errors due to language barriers, and challenges with follow-up care. Before deciding to start a cycle, it is recommended to complete the following three preparations: ① Obtain a comprehensive fertility assessment from a domestic tertiary hospital; ② Have video consultations with doctors from at least two overseas fertility centers to compare protocols and costs; ③ Confirm the overseas center's laboratory accreditation and success rate data for embryo culture/testing (note: request third-party statistical reports, not data promoted by the center itself). Any claims of "guaranteed success," "guaranteed pregnancy," or "money-back guarantee" are not objective; maintain rational judgment.

© Assisted Reproduction Knowledge Base · Patient Education Material from Reproductive Medicine Center | This article was written by the Reproductive Medicine Editorial Team and reviewed by clinical reproductive specialists.

Comments (0)

Leave a Comment